Effects of quebrachitol on cell viability, apoptosis, and reactive oxygen species production in high glucose-induced Schwann cells

Acta Neurochirurgica · Springer Nature · 2026-10-15 · DOI: 10.1007/s42464-026-00413-x

Abstract

Quebrachitol, an active cyclitol derived as a by-product from the latex of Hevea brasiliensis , has demonstrated potential therapeutic benefits in managing diabetes-related complications. This study investigated the effects of quebrachitol on Schwann cells exposed to high glucose (100 mM) to determine its influence on key mechanisms associated with diabetic neuropathy, including cell viability, apoptosis, and reactive oxygen species (ROS) production resulting from oxidative stress. Cell viability was evaluated using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Intracellular ROS levels were measured using the 2′,7′-dichlorodihydrofluorescein diacetate (DCFH-DA) assay, and Hoechst 33342 fluorescence staining was used to visualise apoptotic nuclear changes. All experiments were performed in triplicate, and results were analysed by one-way analysis of variance (ANOVA) with SPSS software. The study demonstrated that high-glucose-induced Schwann cells treated with quebrachitol (3.125 µg/mL) showed significantly improved cell viability ( p < 0.05) compared with the high glucose group, without inducing cytotoxicity when administered alone. Furthermore, quebrachitol reduced high-glucose-induced apoptosis and ROS accumulation, suggesting that it possesses antioxidant and cytoprotective properties. Further in vivo studies are warranted to validate the neuroprotective potential of quebrachitol in diabetic neuropathy.

Read at publisher →

Similar articles